Literature DB >> 3857583

Multiply drug-resistant human KB carcinoma cells have decreased amounts of a 75-kDa and a 72-kDa glycoprotein.

N Richert, S Akiyama, D Shen, M M Gottesman, I Pastan.   

Abstract

Human KB carcinoma cells were selected in sequential steps for resistance to colchicine and found to be cross-resistant to multiple drugs, including vinblastine, adriamycin, and actinomycin D. Compared with the parental line, the multiply resistant cells have decreased amounts of two [35S]methionine-labeled proteins with apparent molecular masses of 75 and 72 kDa. These proteins reappear in a revertant, drug-sensitive cell line. Both proteins are labeled with [14C]glucosamine and are retained on a wheat germ agglutinin-agarose column, indicating that they are glycoproteins. These data suggest that in this human cell line, these two glycoproteins can serve as a marker of the multiple drug-resistance phenotype and may play a role in its etiology.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3857583      PMCID: PMC397551          DOI: 10.1073/pnas.82.8.2330

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

3.  Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts.

Authors:  W T Beck; T J Mueller; L R Tanzer
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

4.  Dominance of colchicine resistance in hybrid CHO cells.

Authors:  V Ling; R M Baker
Journal:  Somatic Cell Genet       Date:  1978-03

5.  Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability.

Authors:  J R Riordan; V Ling
Journal:  J Biol Chem       Date:  1979-12-25       Impact factor: 5.157

6.  DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression.

Authors:  P G Debenham; N Kartner; L Siminovitch; J R Riordan; V Ling
Journal:  Mol Cell Biol       Date:  1982-08       Impact factor: 4.272

7.  Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity.

Authors:  N T Bech-Hansen; J E Till; V Ling
Journal:  J Cell Physiol       Date:  1976-05       Impact factor: 6.384

8.  Continued expression of vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase.

Authors:  W T Beck; M C Cirtain
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

9.  Purification of a tyrosine-specific protein kinase from Rous sarcoma virus-induced rat tumor.

Authors:  D L Blithe; N D Richert; I H Pastan
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

10.  Insulin-induced receptor loss in cultured human lymphocytes is due to accelerated receptor degradation.

Authors:  M Kasuga; C R Kahn; J A Hedo; E Van Obberghen; K M Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

View more
  15 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Overexpression and amplification of five genes in a multidrug-resistant Chinese hamster ovary cell line.

Authors:  A M Van der Bliek; T Van der Velde-Koerts; V Ling; P Borst
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

3.  Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum.

Authors:  S D Bernal; J A Speak; K Boeheim; A I Dreyfuss; J E Wright; B A Teicher; A Rosowsky; S W Tsao; Y C Wong
Journal:  Mol Cell Biochem       Date:  1990-06-01       Impact factor: 3.396

4.  Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation.

Authors:  Chaoyun Pan; Jaemoo Chun; Dan Li; Austin C Boese; Jie Li; JiHoon Kang; Anna Umano; Yunhan Jiang; Lina Song; Kelly R Magliocca; Zhuo G Chen; Nabil F Saba; Dong M Shin; Taofeek K Owonikoko; Sagar Lonial; Lingtao Jin; Sumin Kang
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

5.  Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells.

Authors:  P Gros; J Croop; I Roninson; A Varshavsky; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

6.  Differential amplification and disproportionate expression of five genes in three multidrug-resistant Chinese hamster lung cell lines.

Authors:  M H de Bruijn; A M Van der Bliek; J L Biedler; P Borst
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

7.  Epidermal growth factor regulates the expression of its own receptor.

Authors:  A J Clark; S Ishii; N Richert; G T Merlino; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation.

Authors:  Lingtao Jin; Jaemoo Chun; Chaoyun Pan; Dan Li; Ruiting Lin; Gina N Alesi; Xu Wang; Hee-Bum Kang; Lina Song; Dongsheng Wang; Guojing Zhang; Jun Fan; Titus J Boggon; Lu Zhou; Jeanne Kowalski; Cheng-Kui Qu; Conor E Steuer; Georgia Z Chen; Nabil F Saba; Lawrence H Boise; Taofeek K Owonikoko; Fadlo R Khuri; Kelly R Magliocca; Dong M Shin; Sagar Lonial; Sumin Kang
Journal:  Cancer Cell       Date:  2018-07-19       Impact factor: 31.743

Review 9.  Molecular cytogenetics of multiple drug resistance.

Authors:  P V Schoenlein
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 10.  Antibodies in the study of multiple drug resistance.

Authors:  Y Heike; T Tsuruo
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.